Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β‑catenin signaling pathway
Cited by 12
Related Papers
RANKL inhibition: a new target of treating diabetes mellitus?
|Therapeutic Advances in Endocrinology and Metabolism|2023|22